Literature DB >> 18322932

Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.

Ge Jiang1, Kitae Park, Jiseok Kim, Ki Su Kim, Eun Ju Oh, Hyungu Kang, Su-Eun Han, Yu-Kyoung Oh, Tae Gwan Park, Sei Kwang Hahn.   

Abstract

A novel target specific small interfering RNA (siRNA) delivery system was successfully developed using polyethyleneimine (PEI)-hyaluronic acid (HA) conjugate. Anti-PGL3-Luc siRNA was used as a model system suppressing the PGL3-Luc gene expression. The siRNA/PEI-HA complex with an average size of ca. 21 nm appeared to be formed by electrostatic interaction between the negatively charged siRNA and the positively charged PEI of PEI-HA conjugate. The cytotoxicity of siRNA/PEI-HA complex to B16F1 cells was lower than that of siRNA/PEI complex according to the MTT assay. When B16F1 and HEK-293 cells were treated with fluorescein isothiocyanate (FITC) labeled siRNA/PEI-HA complex, B16F1 cells, with a lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1), showed higher green fluorescent intensity than HEK-293 cells because of the HA receptor mediated endocytosis of the complex. Accordingly, the PGL3-Luc gene silencing of anti-PGL3-Luc siRNA/PEI-HA complex was more efficient in B16F1 cells than in HEK-293 cells. In addition, the inhibited PGL3-Luc gene silencing effect in the presence of free HA in the transfection medium revealed that siRNA/HA-PEI complex was selectively taken up to B16F1 cells via HA receptor mediated endocytosis. All these results demonstrated that the intracellular delivery of anti-PGL3-Luc siRNA/PEI-HA complex could be facilitated by the HA receptor mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322932     DOI: 10.1002/bip.20978

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  26 in total

Review 1.  Human ESC vs. iPSC-pros and cons.

Authors:  Jane J Pappas; Phillip C Yang
Journal:  J Cardiovasc Transl Res       Date:  2008-05-30       Impact factor: 4.132

2.  Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.

Authors:  Hironobu Takahashi; Yuwei Wang; David W Grainger
Journal:  J Control Release       Date:  2010-08-19       Impact factor: 9.776

3.  Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.

Authors:  Shanthi Ganesh; Arun K Iyer; David V Morrissey; Mansoor M Amiji
Journal:  Biomaterials       Date:  2013-02-11       Impact factor: 12.479

Review 4.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

5.  Modulation of polyplex release from biodegradable microparticles through poly(ethylenimine) modification and varying loading concentration.

Authors:  Clark J Needham; Sarita R Shah; Paschalia M Mountziaris; F Kurtis Kasper; Antonios G Mikos
Journal:  Pharm Res       Date:  2013-07-25       Impact factor: 4.200

Review 6.  Nanoparticle-based approaches to target the lymphatic system for antitumor treatment.

Authors:  Xingzhou Peng; Junjie Wang; Feifan Zhou; Qian Liu; Zhihong Zhang
Journal:  Cell Mol Life Sci       Date:  2021-05-08       Impact factor: 9.261

7.  Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid.

Authors:  Clark J Needham; Austin K Williams; Sue Anne Chew; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomacromolecules       Date:  2012-04-11       Impact factor: 6.988

Review 8.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

9.  Polymeric nanoparticles for siRNA delivery and gene silencing.

Authors:  Yogesh Patil; Jayanth Panyam
Journal:  Int J Pharm       Date:  2008-10-01       Impact factor: 5.875

10.  Tracking in vitro and in vivo siRNA electrotransfer in tumor cells.

Authors:  Aurelie Paganin-Gioanni; Elisabeth Bellard; Bettina Couderc; Justin Teissié; Muriel Golzio
Journal:  J RNAi Gene Silencing       Date:  2008-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.